These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32371763)

  • 21. Candesartan cilexetil: an angiotensin II-receptor blocker.
    See S; Stirling AL
    Am J Health Syst Pharm; 2000 Apr; 57(8):739-46. PubMed ID: 10786259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers.
    Jeon H; Lim KS; Shin KH; Kim J; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):84-91. PubMed ID: 21934629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide.
    Aberg JG; Olofsson B; Karlson BW
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):750-5. PubMed ID: 22122817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
    Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
    Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet].
    Lancellotti P
    Rev Med Liege; 2010; 65(7-8):471-5. PubMed ID: 20857707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candesartan cilexetil. A review of its use in essential hypertension.
    McClellan KJ; Goa KL
    Drugs; 1998 Nov; 56(5):847-69. PubMed ID: 9829158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.
    Mugellini A; Nieswandt V
    Expert Opin Pharmacother; 2012 Dec; 13(18):2699-709. PubMed ID: 23170938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
    Wada T; Sanada T; Ojima M; Kanagawa R; Nishikawa K; Inada Y
    Hypertens Res; 1996 Dec; 19(4):247-54. PubMed ID: 8986455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.
    Gorain B; Choudhury H; Halder D; Sarkar AK; Sarkar P; Biswas E; Ghosh B; Pal TK
    Drug Res (Stuttg); 2013 Apr; 63(4):177-84. PubMed ID: 23471702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergisms of cardiovascular effects between iptakalim and amlodipine, hydrochlorothiazide or propranolol in anesthetized rats.
    Zhou HM; Zhong ML; Wang RH; Long CL; Zhang YF; Cui WY; Wang H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Nov; 31(6):532-40. PubMed ID: 27215021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects.
    Sunkara G; Jiang X; Reynolds C; Serra D; Zhang Y; Ligueros-Saylan M; Ayalasomayajula S; Winter S; Jarugula V
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):487-92. PubMed ID: 27129123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs.
    Huang XH; Qiu FR; Xie HT; Li J
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):863-9. PubMed ID: 16306814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects.
    Duan J; Chen J; Yin Q; Karan R; Meiser K; Smith HT; Sunkara G
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):33-43. PubMed ID: 22192643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic drug interaction studies with candesartan cilexetil.
    Jonkman JH; van Lier JJ; van Heiningen PN; Lins R; Sennewald R; Högemann A
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S31-5. PubMed ID: 9331003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
    Czarnecka D; Koch EM; Gottwald-Hostalek U
    Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
    Hedaya MA; Helmy SA
    Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
    Chae JW; Baek IH; Seo JW; Jung SH; Back HM; Song BJ; Lee BY; Yun HY; Kang W; Kwon KI
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):676-83. PubMed ID: 24849193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.